Galmed Pharmaceuticals(股票代码:GLMD)旗下子公司已与Yissum达成一项共同终止协议,正式废除双方于2021年6月28日签署的许可协议。这一行动通过一份联合终止函得以实现,标志着双方合作关系的正式终结。
Galmed Pharmaceuticals(股票代码:GLMD)旗下子公司已与Yissum达成一项共同终止协议,正式废除双方于2021年6月28日签署的许可协议。这一行动通过一份联合终止函得以实现,标志着双方合作关系的正式终结。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.